Eversept Partners, LP
Top Portfolio Positions
110 positions ·
$1,817,420,308 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
264,271 | $156,707,417 | 8.62% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
238,700 | $137,772,866 | 7.58% | |
| ABVX |
Abivax S.A.
Healthcare
|
934,423 | $104,048,001 | 5.73% | |
| GSK |
GSK plc
Healthcare
|
1,785,175 | $98,523,808 | 5.42% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
2,173,286 | $87,431,295 | 4.81% | |
| NTRA |
Natera, Inc.
Healthcare
|
384,713 | $76,938,752 | 4.23% | |
| SPY |
Spdr S&P 500 ETF Trust
|
107,000 | $69,586,380 | 3.83% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
2,885,622 | $67,408,129 | 3.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
1,788,016 | $56,715,867 | 3.12% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
924,193 | $53,704,855 | 2.96% |
Portfolio Trend
25 quarters · across all stocks
Holdings in GSK
Shares Held
Position Value (USD)
15 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $98,523,808 | 1,785,175 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $131,413,517 | 2,679,721 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $91,518,449 | 2,120,446 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $86,107,699 | 2,242,388 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $101,624,550 | 2,623,246 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $123,840,993 | 3,661,768 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $165,858,581 | 4,057,206 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $133,521,080 | 3,468,080 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $161,705,382 | 3,771,994 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $110,177,675 | 2,972,954 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $118,151,147 | 3,259,342 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $102,679,267 | 2,881,012 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $132,766,734 | 3,731,499 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $122,654,658 | 3,490,457 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $86,496,830 | 2,939,070 | Shares | Sole | 2022-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||